Clinical Trials for BRCA2 Gene Mutation

Find clinical trials for brca2 gene mutation. Discover research opportunities and treatment options in your area.

3 Active Trials Found

Showing 3 trials on this page

Page 1 of 1

Niraparib, Abiraterone Acetate and Prednisone for mHSPC With Deleterious Homologous Recombination Repair Alterations

NCT ID: NCT06392841

This clinical trial is studying a combination of three medications—Niraparib, Abiraterone Acetate, and Prednisone— to see how well they work for men with metastatic hormone-sensitive prostate cance...

Recruiting

Phase: PHASE2 Type: interventional Locations: Dallas, Texas, United States

Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects

NCT ID: NCT04030559

This clinical trial is studying how effective a medication called niraparib is when given to men with high-risk localized prostate cancer before they have surgery. The trial specifically focuses on...

Recruiting

Phase: PHASE2 Type: interventional Locations: Sacramento, California, United States

TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention

NCT ID: NCT04294927

This clinical trial is looking at a new way to help reduce the risk of ovarian cancer in women who have certain genetic mutations that increase their risk, such as BRCA1 and BRCA2. The study is com...

Recruiting

Phase: NA Type: interventional Locations: Rochester, Minnesota, United States, Seattle, Washington, United States +36 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions